COMMUNIQUÉS West-GlobeNewswire

Gala Pharmaceutical Positioned to Significantly Benefit From California’s Cannabis Testing Regulations
28/08/2018
Company Plans to Develop Network of State-of-the-Art Cannabis Testing Labs As it Capitalizes on Current Bottleneck Caused by Regulatory Environment IRVINE, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, [...]
Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR Annual Healthcare Conference
28/08/2018
SHANGHAI, China and CUPERTINO, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]
Toothpic Launches in the US to Deliver Expert Dental Advice Via Smart Phone App
28/08/2018
New tech allows patients to get answers from a real dentist, access a directory of dentists in their area and receive reports and treatment options at home NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Toothpic , an app [...]
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
28/08/2018
Clinical Trial Data Presented at European Society of Cardiology in Munich DUBLIN and MUNICH - August 28, 2018 - Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial [...]
NSS Labs to Develop its 2019 Next Generation Firewall Group Test
28/08/2018
Company Invites Industry Engagement to Help Evolve Forthcoming NGFW Test and Methodology AUSTIN, Texas, Aug. 28, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based [...]
Ceapro Inc. Reports 2018 Second Quarter and Six-Month Financial Results and Operational Highlights
28/08/2018
EDMONTON, Alberta, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSX-V: CZO) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]
Grown Rogue Brand Fills an Important Marketing Void with its Seed-to-Experience Model -- CFN Media
28/08/2018
Seattle, Washington, Aug. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
Retail is King in the Burgeoning Cannabis Industry -- CFN Media
28/08/2018
SEATTLE, Aug. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Why Are Beverage Companies So Interested in Cannabis? -- CFN Media
28/08/2018
SEATTLE, Aug. 28, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
Biohit Oyj: Managers' Transactions
28/08/2018
BIOHIT OYJ MANAGERS’ TRANSACTIONS 28 AUGUST 2018 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Semi Korpela Position: Chief Executive Officer Issuer: Biohit Oyj LEI: [...]
CV Sciences, Inc. Responds to Class Action Lawsuit
28/08/2018
LAS VEGAS, Aug. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) has been informed of a class action lawsuit filed against the Company that alleges [...]
Delcath Announces Extension of Rights Offering Period to September 26, 2018
28/08/2018
NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH ), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has completed the [...]
Avinger Announces Participation in Upcoming Investor Conferences
28/08/2018
REDWOOD CITY, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that management of Avinger will [...]
Galectin Therapeutics to Present at H.C. Wainwright 20th Annual Global Investment Conference
28/08/2018
NORCROSS, Ga., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold H. Shlevin, the Company’s [...]
Arbutus to Participate at the 2018 B. Riley FBR Healthcare Conference
28/08/2018
WARMINSTER, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia, Arbutus [...]
AzurRx BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference on September 5th
28/08/2018
BROOKLYN, N.Y., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018
28/08/2018
WOBURN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a company focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security [...]
Hemispherx Releases Recently Manufactured Ampligen for Pancreatic Cancer Early Access Program in the Netherlands to Fill Stock Order
28/08/2018
ORLANDO, Fla., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announced today that the new Ampligen batch manufactured earlier this year is now released for patients' use in the [...]
Onconova Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference in New York City
28/08/2018
NEWTOWN, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]

Pages